$95 million for Marketing Medical Drugs
May 2, 2013
Through a Qui Tam case involving a company named Boehringer Ingelheim Pharmaceuticals Inc., whistleblower Robert Heiden, a former sales representative for Boehringer, received over $17 million for bringing up the case. Boehringer promoted Aggrenox, Atrovent, Combivent and Micardis – medical drugs – and prescribed them for the incorrect treatment and
